ELYM — Eliem Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSmall CapNeutral

Annual balance sheet for Eliem Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	21.2	20.5	136	124	107
Prepaid Expenses
Total Other Current Assets
Total Current Assets	21.3	22	148	134	110
Net Property, Plant And Equipment	—	—	—	0.471	0.199
Other Long Term Assets
Total Assets	21.4	24.6	173	135	110
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	0.783	3.06	6.04	6.1	2.83
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	0.783	3.06	6.04	6.28	2.87
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	20.6	21.6	167	129	108
Total Liabilities & Shareholders' Equity	21.4	24.6	173	135	110
Total Common Shares Outstanding
Total Preferred Shares Outstanding